Skip to main content

DUK 2023 P257 Ryder Endobarrier Poster

EndoBarrier treatment for longstanding type 2 diabetes and obesity: A comparison of the outcomes with an implantation period of 9 months versus 12 months in 90 consecutive EndoBarrier treated patients RESULTS Table 1: 78/90 (87%) patients attended review at both 9-months and 12-months after EndoBarrier implantation. Baseline characteristics: .

Authors: REJ Ryder, M Yadagiri, W Burbridge, SP Irwin, T Bashir, MC Wyres, ML Cull, JP Bleasdale, RA Allden, EN Fogden, M Anderson and P Sen Gupta.

Resource taxonomy
Clinical taxonomy
Listing status